daunorubicin has been researched along with Nervous System Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chatterjee, DR; Contractor, D; Jain, A; Kumar, D; Nagpure, M; Rana, P; Satpute, DP; Vaidya, GN; Venkatesh, A | 1 |
| Carlson, NG; Clawson, SA; Greenlee, JE; Hill, KE; Rose, JW | 1 |
| Desser, RK; Ultmann, JE | 1 |
2 review(s) available for daunorubicin and Nervous System Diseases
| Article | Year |
|---|---|
Paradigm shift of "classical" HDAC inhibitors to "hybrid" HDAC inhibitors in therapeutic interventions.
Topics: Animals; Cardiovascular Diseases; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Humans; Molecular Targeted Therapy; Neoplasms; Nervous System Diseases | 2021 |
The sensitivity of Hodgkin's disease to chemotherapeutic agents administered singly.
Topics: Adrenal Cortex Hormones; Alopecia; Antineoplastic Agents; Bleomycin; Blood Platelet Disorders; Carmustine; Chlorambucil; Cyclophosphamide; Daunorubicin; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukopenia; Mechlorethamine; Mitolactol; Nervous System Diseases; Procarbazine; Remission, Spontaneous; Streptonigrin; Vinblastine; Vincristine | 1973 |
1 other study(ies) available for daunorubicin and Nervous System Diseases
| Article | Year |
|---|---|
Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics.
Topics: Animals; Antibiotics, Antineoplastic; Cells, Cultured; Cerebellum; Daunorubicin; Humans; Immunoglobulin G; Immunoglobulin M; Immunotherapy; Immunotoxins; Nervous System Diseases; Purkinje Cells; Rats; Rats, Sprague-Dawley | 2009 |